Current Chemours Company (NYSE: CC) shareholders who have held shares of the Company’s stock since at least February 10, 2023, have standing to seek corporate reforms, the return of funds back to company coffers and potentially a court approved incentive award if appropriate.

The Chemours Company is an industrial and specialty chemical company for a number of markets including the “coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas” markets.

According to an underlying securities fraud class action complaint, Chemours, via certain of its officers and directors, made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company’s business and operations including that: (1) certain of the Company’s senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to the Company’s Annual Incentive Plans (“AIPs”) and Long-Term Incentive Plans (“LTIPs”); (2) the Company’s accounting practices and procedures, including its internal control over financial reporting, were deficient; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

If you have held Chemours shares since prior to February 10, 2023 and would like to learn more at no cost to you, please contact Joshua Grabar at jgrabar@grabarlaw.com or Mia Heller at mheller@grabarlaw.com, or call us at 267-507-6085. You may also join this action directly on this page.